Paradigm Financial Advisors »

Bioxcel Therapeutics shares owned by Paradigm Financial Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics shares owned by Paradigm Financial Advisors from 13F filings

Historical chart of Paradigm Financial Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Paradigm Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Paradigm Financial Advisors

Quarter filed Position value Share count Share price at filing
2021-12-31 $16k 800 20.00

More positions owned by Paradigm Financial Advisors

Apple (AAPL)
Ishares Barclays TIPS Bond Fun Etf (TIP)
Invesco Qqq Trust Series 1 (QQQ)
Qualcomm (QCOM)
Bank of America Corporation (BAC)
Vanguard Value ETF Etf (VTV)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
iShares Russell 2000 Value ETF Etf (IWN)
NASDAQ Clean Energy ETF Etf (QCLN)
Vanguard SmCap ETF Etf (VB)
Vanguard Dividend Appreciation Etf (VIG)
Amazon (AMZN)
Vanguard Mid Cap ETF Etf (VO)
Invesco China Technology Etf (CQQQ)

View all positions for Paradigm Financial Advisors